Data Issues: Neuroscience

[anonymous]

Who else in NS is experiencing significant data issues? Do we have a class action lawsuit on our hands? First Genoa, now accredo. This is twice now that they have partnered with a specialty pharmacy and labeled it as a value add to customers with “enhanced” capabilities, only to find out long down the road neither of those SPs report. Our senior leaders line their pockets with our hard work while many of us are left with PIPs.

 

[Anonymous]

Who else in NS is experiencing significant data issues? Do we have a class action lawsuit on our hands? First Genoa, now accredo. This is twice now that they have partnered with a specialty pharmacy and labeled it as a value add to customers with “enhanced” capabilities, only to find out long down the road neither of those SPs report. Our senior leaders line their pockets with our hard work while many of us are left with PIPs.

Pick a region....the data is full of shit. They know it......but they don't care. Leave while you can before the Pdot boogy man gets you too.

 

[anonymous]

Who else in NS is experiencing significant data issues? Do we have a class action lawsuit on our hands? First Genoa, now accredo. This is twice now that they have partnered with a specialty pharmacy and labeled it as a value add to customers with “enhanced” capabilities, only to find out long down the road neither of those SPs report. Our senior leaders line their pockets with our hard work while many of us are left with PIPs.

Neither of them are reporting and I heard from a few SPs that our competitors are gaining tracking. They are being aggressive with rebates and physicians like the 1 shot vs 2 starter. Also uzedy is picking up in many territories.